Courtney P Williams1, Gabrielle B Rocque1, Andres Azuero2, Kelly M Kenzik1, Grant R Williams1, Pradeep Sharma3, Rodney P Rocconi4, Wendy Demark-Wahnefried5, Michelle Y Martin6, Maria Pisu7. 1. Division of Hematology & Oncology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA. 2. UAB School of Nursing, University of Alabama at Birmingham (UAB), Birmingham, AL, USA. 3. UAB School of Public Health, University of Alabama at Birmingham (UAB), Birmingham, AL, USA. 4. University of South Alabama Mitchell Cancer Institute, Mobile, AL, USA. 5. UAB Department of Nutrition Sciences, University of Alabama at Birmingham (UAB), Birmingham, AL, USA. 6. Department of Preventive Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA. 7. UAB Division of Preventative Medicine, University of Alabama at Birmingham (UAB), MT 636, 1720 2nd Avenue South, Birmingham, AL, 35294, USA. mpisu@uabmc.edu.
Abstract
PURPOSE: Though lay navigation programs have proven beneficial for individuals during cancer treatment, little is known about the effects of lay navigation on health care utilization and Medicare spending among older adults during cancer survivorship. METHODS: This retrospective cohort study used administrative claims data to evaluate a lay navigation program implemented from 2012 to 2015 at 12 academic and community cancer centers in the Southeast. Medicare beneficiaries age ≥65 years navigated during survivorship were compared to propensity score-matched, non-navigated cancer survivors. Quarterly trends in Medicare spending were estimated using repeated measures mixed models. Rate ratios (RRs) and 95% confidence intervals (CIs) were estimated using repeated measures generalized linear models for quarterly emergency room (ER) visits and hospitalizations. RESULTS: Medicare spending for navigated (n = 3255) versus non-navigated older cancer survivors (n = 3255) was initially higher but declined faster by $513 per patient per quarter (95% CI -$616, -$410). Per patient per quarter risk of ER visits decreased by 11% (RR 0.89, 95% CI 0.86, 0.92) and hospitalizations decreased by 16% (RR 0.84, 95% CI 0.81, 0.88) over time comparing navigated versus non-navigated patients. Similar results were seen for patients enrolled in navigation post-treatment (N = 1893). CONCLUSIONS: In older cancer survivors receiving care in the Deep South, patients receiving lay navigation compared to those non-navigated had significant reductions in Medicare spending, hospitalizations, and ER visits. IMPLICATIONS FOR CANCER SURVIVORS: Though much emphasis has been placed on lay navigation during initial cancer treatment, navigation is needed throughout survivorship due to the high costs and health care utilization that persist post-treatment.
PURPOSE: Though lay navigation programs have proven beneficial for individuals during cancer treatment, little is known about the effects of lay navigation on health care utilization and Medicare spending among older adults during cancer survivorship. METHODS: This retrospective cohort study used administrative claims data to evaluate a lay navigation program implemented from 2012 to 2015 at 12 academic and community cancer centers in the Southeast. Medicare beneficiaries age ≥65 years navigated during survivorship were compared to propensity score-matched, non-navigated cancer survivors. Quarterly trends in Medicare spending were estimated using repeated measures mixed models. Rate ratios (RRs) and 95% confidence intervals (CIs) were estimated using repeated measures generalized linear models for quarterly emergency room (ER) visits and hospitalizations. RESULTS: Medicare spending for navigated (n = 3255) versus non-navigated older cancer survivors (n = 3255) was initially higher but declined faster by $513 per patient per quarter (95% CI -$616, -$410). Per patient per quarter risk of ER visits decreased by 11% (RR 0.89, 95% CI 0.86, 0.92) and hospitalizations decreased by 16% (RR 0.84, 95% CI 0.81, 0.88) over time comparing navigated versus non-navigated patients. Similar results were seen for patients enrolled in navigation post-treatment (N = 1893). CONCLUSIONS: In older cancer survivors receiving care in the Deep South, patients receiving lay navigation compared to those non-navigated had significant reductions in Medicare spending, hospitalizations, and ER visits. IMPLICATIONS FOR CANCER SURVIVORS: Though much emphasis has been placed on lay navigation during initial cancer treatment, navigation is needed throughout survivorship due to the high costs and health care utilization that persist post-treatment.
Authors: Gabrielle B Rocque; Jacqueline A Mullvain; Jens Eickhoff; James F Cleary; Toby C Campbell Journal: Palliat Med Date: 2015-09-02 Impact factor: 4.762
Authors: Gabrielle B Rocque; Edward E Partridge; Maria Pisu; Michelle Y Martin; Wendy Demark-Wahnefried; Aras Acemgil; Kelly Kenzik; Elizabeth A Kvale; Karen Meneses; Xuelin Li; Yufeng Li; Karina I Halilova; Bradford E Jackson; Carol Chambless; Nedra Lisovicz; Mona Fouad; Richard A Taylor Journal: J Oncol Pract Date: 2016-05-10 Impact factor: 3.840
Authors: Maria Pisu; Andres Azuero; Karina I Halilova; Courtney P Williams; Kelly M Kenzik; Elizabeth A Kvale; Grant R Williams; Karen Meneses; Margaret Sullivan; Supriya Kumar Yagnik; Hans-Peter Goertz; Gabrielle B Rocque Journal: Cancer Date: 2017-12-18 Impact factor: 6.860
Authors: Stacie B Dusetzina; Aaron N Winn; Gregory A Abel; Haiden A Huskamp; Nancy L Keating Journal: J Clin Oncol Date: 2013-12-23 Impact factor: 44.544
Authors: Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz Journal: J Clin Oncol Date: 2009-04-29 Impact factor: 44.544
Authors: Naomi Y Ko; Frederick R Snyder; Peter C Raich; Electra D Paskett; Donald J Dudley; Ji-Hyun Lee; Paul H Levine; Karen M Freund Journal: Cancer Date: 2016-05-26 Impact factor: 6.860
Authors: Gabrielle B Rocque; Maria Pisu; Bradford E Jackson; Elizabeth A Kvale; Wendy Demark-Wahnefried; Michelle Y Martin; Karen Meneses; Yufeng Li; Richard A Taylor; Aras Acemgil; Courtney P Williams; Nedra Lisovicz; Mona Fouad; Kelly M Kenzik; Edward E Partridge Journal: JAMA Oncol Date: 2017-06-01 Impact factor: 31.777
Authors: Courtney P Williams; Amy Davidoff; Michael T Halpern; Michelle Mollica; Kathleen Castro; Benjamin Allaire; Janet S de Moor Journal: JCO Oncol Pract Date: 2022-08